Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
Evofem Biosciences Announces Uplisting to OTCQB
October 3, 2022
Related Post
-
-
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 5, 2026
-
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
August 4, 2026
-
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
August 3, 2026